Quyen Dang, MD
Obstetrics & Gynecology · Plano, TXNPI 1033347604
Payments from drug & device makers
Across 156 payments — averaging $85.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$11K
- AbbVie$310
- Pfizer$256
- Organon$199
- Hologic Sales And Service, LLC$164
- Astellas Pharma US Inc$163
- plus $2K from 36 others
What the payments were for
- Consulting fees$10,60079%
- Food & beverage$2,76421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 19 | $10,600 |
| AbbVie | 16 | $310 |
| Pfizer | 17 | $256 |
| Organon | 10 | $199 |
| Hologic Sales And Service, LLC | 4 | $164 |
| Astellas Pharma US Inc | 9 | $163 |
| Exeltis, USA Inc. | 9 | $162 |
| Innovation Technologies Inc | 5 | $156 |
| Myriad Women's Health, Inc. | 1 | $143 |
| Gynesonics, Inc. | 1 | $133 |
| Mayne Pharma Commercial LLC | 10 | $92 |
| Bayer | 4 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Millicent US Inc | 3 | $54 |
| Sage Therapeutics, LLC | 3 | $54 |
| Therapeuticsmd, Inc. | 4 | $53 |
| Merck | 4 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $46 |
| Myovant Sciences Inc. | 2 | $44 |
| Avanos Medical | 1 | $41 |
| Coloplast | 1 | $36 |
| Boston Scientific | 2 | $36 |
| Smith+Nephew | 2 | $36 |
| Baxter Healthcare | 2 | $32 |
| Axonics, Inc. | 2 | $31 |
| Monaghan Medical Corporation | 1 | $29 |
| Evofem Biosciences, Inc. | 2 | $29 |
| Mylan Pharmaceuticals Inc. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| American Regent | 1 | $26 |
| Edwards Lifesciences | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Coopersurgical, Inc. | 1 | $19 |
| BD | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Minerva Surgical, Inc | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Acessa Health Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Meditrina | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,364 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 99 | $3,995 |
| Raloxifene Hcl | 13 | $743 |
| Medroxyprogesterone Acetate | 36 | $289 |
| Fluoxetine Hcl | 11 | $0 |
| Levothyroxine Sodium | 11 | $0 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Plano
- John Paul RobertsPlano$4.9M
- Phyllis GeePlano$432K
- Elizabeth CoronadoPlano$155K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.